NEW DELHI, April 21 (Reuters) - The Serum Institute of India
will be able to raise its monthly output of the AstraZeneca
COVID-19 vaccine to 100 million doses by July from 60-70 million
now, later than a previous timeline of end-May, its chief
executive Adar Poonawalla told CNBC-TV18.
(Reporting by Chandini Monappa and Krishna N. Das; Editing by
Andrew Heavens)
Astra, Sanofi's antibody 90% effective against RSV in infants - CDC
(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.
Read more